Magnetar Financial LLC Incyte Corp Transaction History

Magnetar Financial LLC

  • $3.44 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$56.55 - $66.59 $1.8 Million - $2.12 Million
31,893 New
31,893 $1.82 Million
Q3 2023

Nov 14, 2023
BUY
$57.77 - $65.93 $200,750 - $229,106
3,475 New
3,475 $200,000
Q1 2023

May 15, 2023
BUY
$70.23 - $86.01 $519,421 - $636,129
7,396 New
7,396 $534,000
Q1 2022

May 16, 2022
SELL
$66.02 - $79.71 $1.44 Million - $1.73 Million
-21,752 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$63.34 - $74.11 $1.38 Million - $1.61 Million
21,752 New
21,752 $1.6 Million
Q3 2021

Nov 12, 2021
SELL
$68.67 - $84.02 $251,400 - $307,597
-3,661 Closed
0 $0
Q2 2021

Aug 06, 2021
SELL
$79.87 - $87.53 $82,026 - $89,893
-1,027 Reduced 21.91%
3,661 $308,000
Q1 2021

May 14, 2021
SELL
$76.02 - $100.5 $362,007 - $478,581
-4,762 Reduced 50.39%
4,688 $381,000
Q4 2020

Feb 12, 2021
BUY
$80.74 - $97.7 $555,168 - $671,785
6,876 Added 267.13%
9,450 $822,000
Q3 2020

Nov 16, 2020
SELL
$85.07 - $109.69 $163,079 - $210,275
-1,917 Reduced 42.69%
2,574 $231,000
Q2 2018

Aug 14, 2018
SELL
$60.85 - $83.98 $52,270 - $72,138
-859 Reduced 16.06%
4,491 $301,000
Q4 2017

Feb 14, 2018
BUY
$93.56 - $116.6 $176,921 - $220,490
1,891 Added 54.67%
5,350 $507,000
Q3 2017

Nov 14, 2017
BUY
$109.15 - $138.27 $377,549 - $478,275
3,459
3,459 $404,000

Others Institutions Holding INCY

# of Institutions
643
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email